Publications

Search for a publication

List of publications

Sort by: Date | Author | Title

van Nieuwenhoven, F. A., Jensen, L. J. N., Flyvbjerg, A. & Goldsmelling, R. (2005). Imballance of growth factor signalling in diabetic kidney disease: Is connective tissue growth factor (CTGF,CCN2) the perfect intervention point? Nephrology Dialysis Transplantation, 20, 6-10.
Witczak, C., Jessen, N., Hotamisligil, G. S., Hirshman, M. F. & Goodyear, L. J. (2005). JNK1 deficiency enhances whole body glucose metabolism, but not via alterations in skeletal muscle. Abstract from American Diabetes Association 65th Scientific Sessions, San Diego, CA, USA , United States.
Zhang, Z., Shahinfar, S., Keane, W. F., Ramjit, D., Dickson, T. Z., Gleim, G. W., Mogensen, C. E. S., de Zeeuw, D., Brenner, B. M. & Snapinn, S. M. (2005). Importance of baseline distribution of proteinuria in renal outcomes trials. Lessons from the Reduction of Endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study. Journal of the American Society of Nephrology, 16, 1775-1780.
Andersen, N. H. & Mogensen, C. E. (2004). Dual blockade of the Renin Angiotensin System in Diabetic and non Diabetic Kidney Disease. Current Hypertension Reports, 6(5), 369-376.
Andersen, N. H. & Mogensen, C. E. (2004). Dualblokade af renin-angiotensin-systemet. Ugeskrift for Læger, 166(43), 3799-3803.
Andersen, N. H., Terkelsen, C. J., Sloth, E. & Poulsen, S. H. (2004). Influence of preload alterations on parameters of systolic left ventricular long-axis function: A Doppler tissue study. Journal of the American Society of Echocardiography, 17(9), 941-947.